down arrow

Senores Pharma.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE0RB801010
  • NSEID: SENORES
  • BSEID: 544319
INR
550.80
34.6 (6.7%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 5.95 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

5.95 lacs (-7.85%) Volume

Shareholding (Jul 2024)

FII

0.00%

Held by 0 FIIs

DII

33.34%

Held by 1 DIIs

Promoter

66.66%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

With a Operating Losses, the company has a Weak Long Term Fundamental Strength

  • Low ability to service debt as the company has a high Debt to EBITDA ratio of 5.66 times
2

Flat results in Dec 24

3

With ROCE of 7.2, it has a Very Expensive valuation with a 5.9 Enterprise value to Capital Employed

 
stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 2,537 Cr (Small Cap)

stock-summary
P/E

76.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

1.15

stock-summary
Return on Equity

15.40%

stock-summary
Price to Book

11.64

Revenue and Profits (1 Year):
Net Sales:
10 Cr
(Quarterly Results - Dec 2024)
Net Profit:
1 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Icon
Company does not have enough history
Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0.00%
EBIT Growth (5y)
0.00%
EBIT to Interest (avg)
3.34
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
1.24
Sales to Capital Employed (avg)
0.17
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
24.12%
ROCE (avg)
-0.82%
ROE (avg)
15.40%
Valuation key factors
Factor
Value
P/E Ratio
76
Industry P/E
33
Price to Book Value
11.64
EV to EBIT
82.73
EV to EBITDA
62.80
EV to Capital Employed
5.94
EV to Sales
12.18
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
7.18%
ROE (Latest)
15.40%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
RSI
Bollinger Bands
KST
Dow Theory
No Trend
OBV
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Jul 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Swapnil Jatin Shah (7.72%)

Highest Public shareholder

Icici Prudential Equity Savings Fund (2.94%)

Individual Investors Holdings

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "9.59",
          "val2": "8.91",
          "chgp": "7.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-2.42",
          "val2": "-0.53",
          "chgp": "-356.60%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2.70",
          "val2": "0.67",
          "chgp": "302.99%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "1.07",
          "val2": "0.20",
          "chgp": "435.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-25.23%",
          "val2": "-5.95%",
          "chgp": "-19.28%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Senores Pharma."
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Senores Pharma."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "34.01",
          "val2": "12.38",
          "chgp": "174.72%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.07",
          "val2": "-1.78",
          "chgp": "96.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.71",
          "val2": "2.14",
          "chgp": "26.64%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.81",
          "val2": "1.20",
          "chgp": "-32.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-0.21%",
          "val2": "-14.38%",
          "chgp": "14.17%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Dec'24 - QoQstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
9.59
8.91
7.63%
Operating Profit (PBDIT) excl Other Income
-2.42
-0.53
-356.60%
Interest
2.70
0.67
302.99%
Exceptional Items
0.00
0.00
Standalone Net Profit
1.07
0.20
435.00%
Operating Profit Margin (Excl OI)
-25.23%
-5.95%
-19.28%
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
34.01
12.38
174.72%
Operating Profit (PBDIT) excl Other Income
-0.07
-1.78
96.07%
Interest
2.71
2.14
26.64%
Exceptional Items
0.00
0.00
Standalone Net Profit
0.81
1.20
-32.50%
Operating Profit Margin (Excl OI)
-0.21%
-14.38%
14.17%
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

stock-summaryCompany CV
About Senores Pharmaceuticals Ltd stock-summary
stock-summary
Senores Pharmaceuticals Ltd
Small Cap
Pharmaceuticals & Drugs
Senores Pharmaceuticals Limited was originally incorporated as "Senores Pharmaceuticals Private Limited" through a Certificate of Incorporation dated December 26, 2017, issued by the Registrar of Companies, Central Registration Centre. Thereafter, the name of the Company was changed to "Senores Pharmaceuticals Limited" upon conversion to a Public Limited Company and a fresh Certificate of Incorporation dated September 4, 2023, was issued by the RoC to the Company.
Company Coordinates stock-summary
Icon
No Company Details Available